Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
On the precision oncology front, expanded larotrectinib data will focus on efficacy and safety findings for pediatric and adult patients with NTRK gene fusion-positive solid tumors
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
The Congress was held on June, 20-21, 2022 in Berlin, Germany
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply chain logistics, route of administration, and packaging innovation, as well from the wider industry for patient-centric design and eco-design
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness
Subscribe To Our Newsletter & Stay Updated